GLP-1 drugs, synthetic versions of a natural hormone, are revolutionizing weight loss and type 2 diabetes treatment. By ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

An expert said weight loss drugs might help people see faster results, which can give them encouragement to continue. But he ...

As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn acquisition of ...

Lilly tops Q3 estimates as Mounjaro and Zepbound fuel a 54% revenue surge, prompting the drugmaker to raise its full-year ...

Amy Schumer feels "so grateful" to be pain free following her recent spinal surgery and endometriosis treatment.

U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled, to $3.57 billion, in the third quarter. Meanwhile, ...

Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion ...

Amy Schumer’s vibrant appearance in the red dress is more than a fashion statement; it's a visible marker of a hard-won ...

Elizabeth Zinni, owner of the Zinni Family Practice in Canfield, was indicted on two counts of sale or use of drugs not ...